Wistron’s board of directors approved a significant increase in the capital expenditure budget for its Fremont, California-based wholly-owned subsidiary WisLab EMS Corporation, doubling it from US$71 million to US$143.6 million. The board also authorized the issuance of a third overseas unsecured convertible bond with a tentative cap of US$1.2 billion and a five-year issuance period.

administrator
Related Articles
Creating a Culture of Quality in Fast-Melt Tablet…
- September 18, 2025
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses,…
- September 18, 2025
NCPA Announces Keynote Speaker for Annual Convention
- September 18, 2025